Obesity and breast cancer prognosis: An expanding body of evidence

Annals of Oncology

Volumn 15, Issue 6, 2004, Pages 850-851

  Dignam, J J ^a,b   Mamounas, E P ^c,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c Aultman Cancer Center   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL PROTOCOL; COMORBIDITY; CONSENSUS DEVELOPMENT; DISEASE ASSOCIATION; EDITORIAL; ENERGY BALANCE; ETHNOLOGY; FEMALE; HEALTH BEHAVIOR; HUMAN; LYMPH NODE METASTASIS; MEDICAL RESEARCH; OBESITY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RACE; RECURRENCE RISK; SMOKING; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 3442899115     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh241     Document Type: Editorial

References (15)

1. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565-574.
2. Josefson D. Obesity fuels cancer epidemic. Br Med J 2001; 322: 945.
3. McCann J. Obesity, cancer links prompt new recommendations. J Natl Cancer Inst 2001; 93: 901-902.
4. van den Brandt P, Spiegelman D, Yaun SS et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-527.
5. Morimoto LM, White E, Chen Z et al. Obesity, body size and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13: 741-751.
6. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-1226.
7. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res Treat 1990; 16: 205-214.
8. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002; 20: 1128-1143.
9. Berclaz G, Li S, Price KN et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004; 15: 875-884.
10. Dignam JJ, Wieand K, Johnson K et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early stage breast cancer. J Natl Cancer Inst 2003; 95: 1467-1476.
11. Lee CW, Norris B, Moravan V, Olivatto O. Does body mass index influence the effectiveness of adjuvant tamoxifen in postmenopausal women with early stage breast cancer? Breast Cancer Res Treat 2003; 82 (Suppl 1): (Abstr 309).
12. Rosner GL, Hargis JB, Hollis DR et al. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 1996; 14: 3000-3008.
13. Cui Y, Whiteman MK, Flaws JA et al. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002; 98: 279-283.
14. Madarnas Y, Sawka CA, Franssen E, Bjarnason GA. Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 2001; 66: 123-133.
15. Demark-Wahnefried W, Peterson BL, Winer EP et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001; 19: 2381-2389.